Endo Cases Highlight Rare Default Risk In Discovery Failures
Default liability judgments because of discovery violations are rare. Endo Pharmaceuticals, however, is facing the threat of two being entered against it in a matter of months, as it fights allegations...To view the full article, register now.
Already a subscriber? Click here to view full article